| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 5,67 | 22,69 | Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs
|
| 1,93 | 9,64 | Monocytic differentiation of leukemic HL-60 cells induced by co-treatment with TNF-alpha and MK886 requires activation of pro-apoptotic machinery
|
| 1,34 | 6,70 | 5 lipoxygenase inhibitors potentiate 1alpha,25 dihydroxyvitamin D3 induced monocytic differentiation by activating p38 MAPK pathway
|
| 3,74 | 14,96 | Alternative pathways of programmed cell death are activated in cells with defective caspase-dependent apoptosis
|
| 2,34 | 9,36 | Autophagy is preferred pathway of camptothecin-induced programmed cell death of v-myb-transformed monoblasts
|
| 0,00 | 0,00 | Autophagy is preferred pathway of camptothecin-induced programmed cell death of v-myb-transformed monoblasts
|
| 1,61 | 11,28 | Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin
|
| 0,00 | 0,00 | Heavy metals induce phosphorylation of the Bcl-2 protein by Jun N-terminal kinase
|
| 4,60 | 23,02 | Heavy metals induce phosphorylation of the Bcl-2 protein by Jun N-terminal kinase
|
| 5,92 | 35,51 | Growth/differentiation factor-15 inhibits differentiation into osteoclasts - A novel factor involved in control of osteoclast differentiation
|
| 0,00 | 0,00 | Growth Differentiation Factor-15 secreted by prostate cancer cells inhibits differentiation of osteoclasts
|
| 0,00 | 0,00 | Regulation of osteoclast differentiation by the TGFbeta proteins secreted by prostate cancer
|
| 0,00 | 0,00 | Proteiny rodiny TGFbeta sekretované prostatickými nádorovými buňkami ovlivňují diferenciaci osteoklastů
|
| 0,00 | 0,00 | Distinct effects of members of the TGFbeta proteins on differentiation of osteoclasts
|
| 1,68 | 6,72 | The effects of TGFb proteins on osteoclast differentiation
|
| 3,04 | 18,26 | Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells
|
Back
(c) Michal Bulant, 2011